Hemodynamic follow-up after valve-in-valve TAVR for failed aortic bioprosthesis.

Manuel WilbringUtz KappertStephan HaussigJohan WinataKlaus MatschkeNorman MangnerSebastian ArztKonstantin Alexiou

Published in: Journal of cardiac surgery (2022)

VIV-TAVR is safe and effective in the early period. In surgical valves with a true-ID ≤21 mm inferior hemodynamic and survival outcomes must be expected. Nonetheless, also patients with larger true-IDs showed steadily increasing transvalvular gradients. This raises concern about durability.

Keyphrases

aortic valve
transcatheter aortic valve replacement
aortic stenosis
aortic valve replacement
transcatheter aortic valve implantation
heart failure
left ventricular
coronary artery disease
coronary artery